These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

607 related items for PubMed ID: 21838332

  • 21. Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in Thailand.
    Sharma M, Ortendahl J, van der Ham E, Sy S, Kim JJ.
    BJOG; 2012 Jan; 119(2):166-76. PubMed ID: 21481160
    [Abstract] [Full Text] [Related]

  • 22. The Clinical and Economic Benefits of Co-Testing Versus Primary HPV Testing for Cervical Cancer Screening: A Modeling Analysis.
    Felix JC, Lacey MJ, Miller JD, Lenhart GM, Spitzer M, Kulkarni R.
    J Womens Health (Larchmt); 2016 Jun; 25(6):606-16. PubMed ID: 27023044
    [Abstract] [Full Text] [Related]

  • 23. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
    Goldie SJ, Weinstein MC, Kuntz KM, Freedberg KA.
    Ann Intern Med; 1999 Jan 19; 130(2):97-107. PubMed ID: 10068381
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing.
    van Rosmalen J, de Kok IM, van Ballegooijen M.
    BJOG; 2012 May 19; 119(6):699-709. PubMed ID: 22251259
    [Abstract] [Full Text] [Related]

  • 28. Cervical cancer prevention in Indonesia: An updated clinical impact, cost-effectiveness and budget impact analysis.
    Setiawan D, Andrijono, Hadinegoro SR, Meyta H, Sitohang RV, Tandy G, Perwitasari DA, Postma MJ.
    PLoS One; 2020 May 19; 15(3):e0230359. PubMed ID: 32203527
    [Abstract] [Full Text] [Related]

  • 29. Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua.
    Campos NG, Mvundura M, Jeronimo J, Holme F, Vodicka E, Kim JJ.
    BMJ Open; 2017 Jun 15; 7(6):e015048. PubMed ID: 28619772
    [Abstract] [Full Text] [Related]

  • 30. Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis.
    Karnon J, Peters J, Platt J, Chilcott J, McGoogan E, Brewer N.
    Health Technol Assess; 2004 May 15; 8(20):iii, 1-78. PubMed ID: 15147611
    [Abstract] [Full Text] [Related]

  • 31. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
    Võrno T, Lutsar K, Uusküla A, Padrik L, Raud T, Reile R, Nahkur O, Kiivet RA.
    Vaccine; 2017 Nov 01; 35(46):6329-6335. PubMed ID: 28899625
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Cost-effectiveness of human papillomavirus vaccination and screening in Spain.
    Diaz M, de Sanjose S, Ortendahl J, O'Shea M, Goldie SJ, Bosch FX, Kim JJ.
    Eur J Cancer; 2010 Nov 01; 46(16):2973-85. PubMed ID: 20638840
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cost and effectiveness evaluation of prophylactic HPV vaccine in developing countries.
    Termrungruanglert W, Havanond P, Khemapech N, Lertmaharit S, Pongpanich S, Khorprasert C, Taneepanichskul S.
    Value Health; 2012 Nov 01; 15(1 Suppl):S29-34. PubMed ID: 22265063
    [Abstract] [Full Text] [Related]

  • 38. Impact and Cost-Effectiveness of Human Papillomavirus Vaccination Campaigns.
    Portnoy A, Campos NG, Sy S, Burger EA, Cohen J, Regan C, Kim JJ.
    Cancer Epidemiol Biomarkers Prev; 2020 Jan 01; 29(1):22-30. PubMed ID: 31666282
    [Abstract] [Full Text] [Related]

  • 39. Cost effectiveness analysis of HPV primary screening and dual stain cytology triage compared with cervical cytology.
    Termrungruanglert W, Khemapech N, Tantitamit T, Havanond P.
    J Gynecol Oncol; 2019 Mar 01; 30(2):e17. PubMed ID: 30740950
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.